Dr. Catherine Benziger, MD, MPH
Claim this profileEssentia Health
Studies Cardiovascular Disease
Studies High Blood Pressure
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Catherine Benziger, MD, MPH is currently running
Combo Diabetes Drug
for Type 2 Diabetes
PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with established T2D and ASCVD or high-risk for ASCVD in a 1:1 allocation to sodium-glucose cotransporter-2 inhibitor (SGLT2i) or glucagon-like peptide-1 receptor agonists (GLP-1RA). Participants will be followed for the occurrence of the trial primary endpoint of the total (first and recurrent) number of episodes of myocardial infarction (MI), stroke, arterial revascularization, hospitalization for heart failure, development of end-stage kidney disease, kidney transplantation, and mortality, counting all events from randomization until end of study.
Recruiting3 awards Phase 48 criteria
Inclisiran
for Cardiovascular Disease
This trial is testing inclisiran, an injectable drug, on people with heart disease who are already on strong cholesterol-lowering medications. The goal is to see if inclisiran can further reduce the risk of heart attacks and strokes by lowering bad cholesterol levels. Participants will receive the injection periodically. Inclisiran works by significantly reducing bad cholesterol levels.
Recruiting1 award Phase 33 criteria
More about Catherine Benziger, MD, MPH
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Catherine Benziger, MD, MPH has experience with
- PedsBP CDS
- Motivational Interview
- SGLT2 Inhibitor
- GLP-1 Receptor Agonist
- Combination Drug
- Inclisiran
Breakdown of trials Catherine Benziger, MD, MPH has run
Cardiovascular Disease
High Blood Pressure
High Cholesterol
Genetic Disorders
Hypercholesterolemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Catherine Benziger, MD, MPH specialize in?
Catherine Benziger, MD, MPH focuses on Cardiovascular Disease and High Blood Pressure. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is Catherine Benziger, MD, MPH currently recruiting for clinical trials?
Yes, Catherine Benziger, MD, MPH is currently recruiting for 3 clinical trials in Duluth Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Catherine Benziger, MD, MPH has studied deeply?
Yes, Catherine Benziger, MD, MPH has studied treatments such as PedsBP CDS, Motivational interview, SGLT2 inhibitor.
What is the best way to schedule an appointment with Catherine Benziger, MD, MPH?
Apply for one of the trials that Catherine Benziger, MD, MPH is conducting.
What is the office address of Catherine Benziger, MD, MPH?
The office of Catherine Benziger, MD, MPH is located at: Essentia Health, Duluth, Minnesota 55805 United States. This is the address for their practice at the Essentia Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.